Inhibikase Therapeutics Inc (IKT)
Investing Cash Flow
-$115.24M
TTM · Period ending: · USD
IKT Investing Cash Flow
Latest reported-$115.24Mperiod ending
Latest reported-$115.24Mperiod ending
IKT TTM Cash from Investing ($0.00 → -$115.24M)
TTM investing cash flow
High-resolution chart · PNG
IKT investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -115,238,239 | |
| -99,485,799 | |
| 2,053,130 | |
| -36,609,748 | |
| -5,337,534 | |
| -12,638,045 | |
| -37,004,201 | |
| -358,071 | |
| 14,177,042 | |
| 14,183,694 | |
| 11,656,666 | |
| 18,735,270 | |
| -19,251,582 | |
| -21,844,550 | |
| -16,005,708 | |
| -20,968,717 | |
| -43,089 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |